MAX SIGHT GROUP Projects First-Half Loss to Surge, Citing Revenue Drop from Expired Contract and Clinic Visits

Stock News
08/11

The company behind MAX SIGHT GROUP (08483) has issued a profit warning, forecasting a significant increase in losses for the first half of the fiscal year.

The group expects to record a loss attributable to owners of the company of approximately HK$3.2 million to HK$3.5 million for the six months ending in 2026. This compares to a loss of about HK$1.1 million reported in the same period of the prior year.

According to the announcement, the anticipated rise in losses is primarily driven by a substantial decline in revenue during the period. The group estimates a revenue drop of no less than approximately HK$8.8 million, down from roughly HK$26.1 million in the corresponding period of 2025.

The revenue reduction is attributed to two main factors. First, in the photography services business, a major service contract expired and was successfully transitioned from a service provision model to a product sales model in April 2025. This change resulted in a revenue decrease of approximately HK$7.0 million compared to the same period in 2025. Second, in the medical services business, the number of clinic visits fell by about 12% during the period, directly leading to a decline in revenue.

Partially offsetting these negative factors, the group's administrative expenses decreased by no less than approximately HK$1.9 million, falling from about HK$0.87 million in the previous year. This reduction in expenses is mainly due to a drop in staff costs, including the impact from the deregistration of a subsidiary operating in the People's Republic of China, as well as a reduction in administrative headcount following the transition of a major service contract from a service to a product model. Additionally, director remuneration decreased following the resignation of an executive director, effective March 23, 2026.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10